Clinical Trials Logo

Filter by:
NCT ID: NCT01369810 Completed - Asthma Clinical Trials

Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease

Start date: July 2011
Phase: N/A
Study type: Observational

To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure

NCT ID: NCT01369693 Completed - Smoking Cessation Clinical Trials

In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus

SMWS03
Start date: May 2004
Phase: Phase 1
Study type: Interventional

In an open label, randomized, two-way cross-over study, 32 male healthy regular snus users will be given repeated doses of four different types of portion snus: "General", "Catch", "Catch Mini" and "Catch Dry Mini". Each portion of used snus will be collected and frozen (-20 oC) pending analysis of lead (Pb), cadmium (Cd), nicotine and tobacco specific nitrosamines (TSNAs). Unused snus is collected and deep frozen for analysis and calculation of extracted dose. Calculations of extracted amount of lead, cadmium, nicotine and tobacco specific nitrosamines (TSNAs) respectively, will be done for each type of snus.

NCT ID: NCT01369511 Completed - Muscular Atrophy Clinical Trials

A Study of LY2495655 in Older Participants Undergoing Elective Total Hip Replacement

Start date: July 2011
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to test the hypothesis that appendicular lean body mass (aLBM) will increase after 12 weeks of LY2495655 treatment versus placebo in older participants undergoing elective total hip arthroplasty (eTHA).

NCT ID: NCT01368016 Completed - Tobacco Dependence Clinical Trials

Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine Gum

Start date: April 2011
Phase: N/A
Study type: Interventional

A comparison of two products for oral nicotine replacement with respect to relief of urges to smoke after single doses of nicotine.

NCT ID: NCT01367665 Completed - Clinical trials for Basal Cell Carcinoma

STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Start date: July 1, 2011
Phase: Phase 2
Study type: Interventional

This single-arm, open-label, multi-center study will evaluate the safety and efficacy of vismodegib (GDC-0449) in patients with locally advanced or metastatic basal cell carcinoma. Patients will receive oral doses of vismodegib 150 mg once daily until disease progression or unacceptable toxicity.

NCT ID: NCT01367418 Completed - Prostate Cancer Clinical Trials

Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomy

AIMS
Start date: September 2010
Phase: Phase 3
Study type: Interventional

Several recently published retrospective studies show that regional anaesthesia (RA) can reduce cancer-related mortality following surgical treatment of colorectal, breast and prostate cancers and malignant melanoma. If these results are true, then the choice of perioperative pain management is as beneficial, or even better, than the current oncological therapies. This theory needs to be investigated in a prospective, randomized and controlled trail. We shall perform a prospective, randomized study comparing the effects of Thoracic epidural analgesia (TEA) or patient controlled analgesia (PCA) on postoperative immunological and inflammatory markers in order to understand whether the protective effects, if any, of regional analgesia are due to changes in these markers or whether the underlying mechanisms is not mediated via this stress signalling pathway.

NCT ID: NCT01366794 Completed - Type 2 Diabetes Clinical Trials

Macronutrients and Gut Hormone Secretion

Start date: September 2011
Phase: N/A
Study type: Interventional

Study hypothesis is to examine the relative contribution of macronutrients for gut hormone secretion after a mixed meal in healthy volunteers and in subjects with type 2 diabetes. Individual macronutrients or a mixed meal will therefore be served and gut hormones are measured during the following 300 min.

NCT ID: NCT01366781 Completed - Normal Non-fluency Clinical Trials

Gut Hormones After Meal Ingestion in Males Versus Females

Start date: May 2011
Phase: N/A
Study type: Interventional

The study hypothesis is that the release of gut hormones is increased proportionally to caloric load in each meal. Three different meals with different meal size will therefore be served and gut hormones determined.

NCT ID: NCT01366768 Completed - Normal Non-fluency Clinical Trials

Gut Hormones After Oral Versus Intravenous Amino Acids

Start date: May 2011
Phase: N/A
Study type: Interventional

The study hypothesis is that gut hormones are released after oral but not intravenous amino acids which result in stimulation of insulin secretion.

NCT ID: NCT01365234 Completed - Heart Failure Clinical Trials

Model 20066 Left Ventricular (LV) Lead Study

Start date: July 2011
Phase: Phase 1
Study type: Interventional

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles through three leads (flexible insulated wires) that are inserted through the veins to the heart. The purpose of this study is to evaluate a new lead for delivering energy to the left ventricle (bottom left chamber of the heart).